Search research articles
Contact Us
Filters
Showing results (101-110 of 127) with videos related to
Page
of 13
Sort By:
Nuclear Medicine and Biology
|
March 22, 2024
Second generation Al<sup>18</sup>F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging
Muriel Aline Spahn, Kaat Luyten, Tom Van Loy, et al.
Cancers
|
March 13, 2025
Comparing <sup>68</sup>Ga-Pentixafor,<sup>18</sup>F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional Study
Bawinile Hadebe, Lerwine Harry, Lerato Gabela, et al.
EJNMMI Reports
|
December 31, 2024
Real world experience with [<sup>99m</sup>Tc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Pete Tually, Virginia García Quinto, Yehia Omar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 18, 2022
mCRPC Patients Receiving <sup>225</sup>Ac-PSMA-617 Therapy in the Post-Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis
Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Diagnostics (Basel, Switzerland)
|
December 30, 2025
Advancements in Renal Imaging: A Comprehensive Systematic Review of PET Probes for Enhanced GFR and Renal Perfusion Assessment
Marwah Abdulrahman, Ahmed Saad Abdlkadir, Serin Moghrabi, et al.
Diagnostics (Basel, Switzerland)
|
July 13, 2024
Chemokine Receptor-4 Targeted PET/CT Imaging with <sup>68</sup>Ga-Pentixafor in Head and Neck Cancer-A Comparison with <sup>18</sup>F-FDG and CXCR4 Immunohistochemistry
Bawinile Hadebe, Lerwine Harry, Lerato Gabela, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 10, 2024
EANM/SNMMI guideline/procedure standard for [<sup>18</sup>F]FDG hybrid PET use in infection and inflammation in adults v2.0
Gad Abikhzer, Giorgio Treglia, Matthieu Pelletier-Galarneau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 19, 2019
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving <sup>225</sup>Ac-PSMA-617 Radioligand Therapy
Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2021
<sup>68</sup>Ga-FAPI-PET/CT in patients with various gynecological malignancies
Katharina Dendl, Stefan A Koerber, Rebecca Finck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 127) with videos related to
Sort By:
Page
of 13
Nuclear Medicine and Biology
|
March 22, 2024
Second generation Al<sup>18</sup>F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging
Muriel Aline Spahn, Kaat Luyten, Tom Van Loy, et al.
Cancers
|
March 13, 2025
Comparing <sup>68</sup>Ga-Pentixafor,<sup>18</sup>F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional Study
Bawinile Hadebe, Lerwine Harry, Lerato Gabela, et al.
EJNMMI Reports
|
December 31, 2024
Real world experience with [<sup>99m</sup>Tc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Pete Tually, Virginia García Quinto, Yehia Omar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 18, 2022
mCRPC Patients Receiving <sup>225</sup>Ac-PSMA-617 Therapy in the Post-Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis
Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Diagnostics (Basel, Switzerland)
|
December 30, 2025
Advancements in Renal Imaging: A Comprehensive Systematic Review of PET Probes for Enhanced GFR and Renal Perfusion Assessment
Marwah Abdulrahman, Ahmed Saad Abdlkadir, Serin Moghrabi, et al.
Diagnostics (Basel, Switzerland)
|
July 13, 2024
Chemokine Receptor-4 Targeted PET/CT Imaging with <sup>68</sup>Ga-Pentixafor in Head and Neck Cancer-A Comparison with <sup>18</sup>F-FDG and CXCR4 Immunohistochemistry
Bawinile Hadebe, Lerwine Harry, Lerato Gabela, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 10, 2024
EANM/SNMMI guideline/procedure standard for [<sup>18</sup>F]FDG hybrid PET use in infection and inflammation in adults v2.0
Gad Abikhzer, Giorgio Treglia, Matthieu Pelletier-Galarneau, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 19, 2019
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving <sup>225</sup>Ac-PSMA-617 Radioligand Therapy
Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2021
<sup>68</sup>Ga-FAPI-PET/CT in patients with various gynecological malignancies
Katharina Dendl, Stefan A Koerber, Rebecca Finck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
Lena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
Page
of 13